FDA.reportPublic FDA data

Tim-Brim-Dor-Lat

Manufacturer
ImprimisRx NJ
Effective date
2018-05-08
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 20:25:41

Label at a glance#

ProductTim-Brim-Dor-Lat
Active ingredientDORZOLAMIDE HYDROCHLORIDE, BRIMONIDINE TARTRATE, LATANOPROST, TIMOLOL MALEATE
Label structure2 sections

Storage and handling

Store under refrigeration 2° to 8° C (36° to 46° F)

Label contents#

Full prescribing information#

STORAGE AND HANDLING SECTION

Store under refrigeration 2° to 8° C (36° to 46° F)

Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Bottle LabelBottle LabelBottle Label

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BRIMONIDINE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20230503
DORZOLAMIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
LATANOPROST Pharmacologic Class Indexing5Indexing - Pharmacologic Class20191108
TIMOLOL ANHYDROUS Pharmacologic Class Indexing4Indexing - Pharmacologic Class20230503

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c6c0c444-a6ba-2fb5-a7bc-7f0443fa5791Product name420251208
973dd458-49b1-1bb1-62c6-b37c4b15fe1fProduct name520251121
8ec6541e-9842-115f-62bf-f7c9ab3aeddbProduct name320250805
f6b0b05b-3bf2-088a-8ccc-e1cf01a91e86Product name420250729
73103a56-9f57-4f32-a306-a42bfa2fea36Product name120250505
425025fc-f910-4afe-815b-58d4486ed4f7Product name420250331
26c5ddae-5c69-622d-e599-5fd583634968Product name420250313
ee780602-134c-4c60-a2f0-e973ba549cd4Product name220250304
39b7fcf4-8865-6d40-d24d-9b8c28bd6345Product name520250123
03f77cb2-b4ad-3c11-8781-787b5ece4291Product name320240507
de829a7d-0b51-4e4d-a051-6a6568f15688Product name120230919
273981e4-09e7-45cc-967c-554f628ededfProduct name320230627
97dad5a2-c524-a7b5-dede-82edefe9ce62Product name720220929
c93ffd9a-5bad-44d8-b5e5-16ef4d2fee72Product name120220316
d11e749b-f93e-0ce3-ceda-28fe03d8081dProduct name220190731
203382e3-d801-4f70-866f-ebe316583560Product name120190624
e516be5e-351f-4b2e-a26b-fdff13181605Product name120181220

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70261-522-052020-01-31C16284748780-19d75b9d1-0171-f424-e053-dadaa90a57ce6ba4f0b3-d776-3485-e053-2991aa0abab3

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70261-522-05Tim-Brim-Dor-Lat5 mL in 1 BOTTLE, DROPPERSOLUTION/ DROPS53

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70261-522TIM-BRIM-DOR-LAT (TIMOLOL - BRIMONIDINE - DORZOLAMIDE - LATANOPROST) SOLUTION/ DROPS [IMPRIMISRX NJ]3Legacy NDC, 1 package rows20180508_6ba4f0b3-d776-3485-e053-2991aa0abab3.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70261-52270261-522-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
DORZOLAMIDE HYDROCHLORIDEQZO5366EW7ACTIM
BRIMONIDINE TARTRATE4S9CL2DY2HACTIB
LATANOPROST6Z5B6HVF6OACTIB
TIMOLOL MALEATEP8Y54F701RACTIM

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
6bb5e498-b278-191a-e053-2a91aa0acab36ba4f0b3-d776-3485-e053-2991aa0abab32018-05-08Exact identifier
spl id: 6bb5e498-b278-191a-e053-2a91aa0acab3
spl set id: 6ba4f0b3-d776-3485-e053-2991aa0abab3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.